Nuvo Pharmaceuticals Inc (MRV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 8,050 | 9,256 | 9,546 | 2,493 | 258 |
| Income taxes - deferred | N/A | N/A | 0 | -225 | N/A |
| Accounts receivable | 1,438 | 9,969 | -3,981 | -974 | 514 |
| Accounts payable and accrued liabilities | 3,140 | -1,411 | -11,698 | N/A | N/A |
| Other Working Capital | 4,894 | 4,810 | -14,069 | 4,061 | 1,658 |
| Other Operating Activity | 3,322 | 1,708 | 22,565 | -8,870 | 2,061 |
| Operating Cash Flow | $20,844 | $24,332 | $2,363 | $-3,515 | $4,491 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -220 | -555 | -83 | -300 | -2,606 |
| Net Acquisitions | N/A | 0 | -2,547 | -138,471 | -8,781 |
| Sale Of Investment | N/A | N/A | 0 | 2,000 | N/A |
| Purchase Sale Intangibles | -22 | -193 | N/A | 0 | -16 |
| Other Investing Activity | 488 | 0 | 0 | -1,876 | 6,000 |
| Investing Cash Flow | $-242 | $-748 | $-2,630 | $-138,647 | $-5,403 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -13,626 | -22,689 | -3,743 | -2 | -2 |
| Common Stock Issued | N/A | N/A | 0 | 123 | 0 |
| Common Stock Repurchased | N/A | N/A | 0 | -748 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 161,658 | 7 |
| Financing Cash Flow | $-13,626 | $-22,689 | $-3,743 | $161,031 | $5 |
| Exchange Rate Effect | 91 | -107 | -1,045 | 807 | -284 |
| Beginning Cash Position | 23,807 | 23,019 | 28,074 | 8,398 | 9,589 |
| End Cash Position | 30,874 | 23,807 | 23,019 | 28,074 | 8,398 |
| Net Cash Flow | $6,976 | $895 | $-4,010 | $18,869 | $-907 |
| Free Cash Flow | |||||
| Operating Cash Flow | 20,844 | 24,332 | 2,363 | -3,515 | 4,491 |
| Capital Expenditure | -730 | -748 | -83 | -300 | -2,622 |
| Free Cash Flow | 20,114 | 23,584 | 2,280 | -3,815 | 1,869 |